WDR26 and MTF2 are therapeutic targets in multiple myeloma.
Sun F, Cheng Y, Riordan JD, Dupuy A, Dubois W, Pisano M, Dong J, Mock B, Zhan F, Hari P, Janz S.
Sun F, et al. Among authors: riordan jd.
J Hematol Oncol. 2021 Dec 7;14(1):203. doi: 10.1186/s13045-021-01217-9.
J Hematol Oncol. 2021.
PMID: 34876184
Free PMC article.